1. Lepromatous leprosy patients produce antibodies that recognise non-bilayer lipid arrangements containing mycolic acids
- Author
-
Isabel Baeza, Carlos Wong-Baeza, Esther Valerdi, Jeanet Serafin-Lopez, Miguel Ibáñez, Sergio Estrada-Parra, Carlos Wong, and Iris Estrada-Garcia
- Subjects
non-bilayer phospholipid arrangements ,mycolic acids ,lepromatous leprosy ,Microbiology ,QR1-502 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Non-bilayer phospholipid arrangements are three-dimensional structures that form when anionic phospholipids with an intermediate structure of the tubular hexagonal phase II are present in a bilayer of lipids. Antibodies that recognise these arrangements have been described in patients with antiphospholipid syndrome and/or systemic lupus erythematosus and in those with preeclampsia; these antibodies have also been documented in an experimental murine model of lupus, in which they are associated with immunopathology. Here, we demonstrate the presence of antibodies against non-bilayer phospholipid arrangements containing mycolic acids in the sera of lepromatous leprosy (LL) patients, but not those of healthy volunteers. The presence of antibodies that recognise these non-bilayer lipid arrangements may contribute to the hypergammaglobulinaemia observed in LL patients. We also found IgM and IgG anti-cardiolipin antibodies in 77% of the patients. This positive correlation between the anti-mycolic-non-bilayer arrangements and anti-cardiolipin antibodies suggests that both types of antibodies are produced by a common mechanism, as was demonstrated in the experimental murine model of lupus, in which there was a correlation between the anti-non-bilayer phospholipid arrangements and anti-cardiolipin antibodies. Antibodies to non-bilayer lipid arrangements may represent a previously unrecognised pathogenic mechanism in LL and the detection of these antibodies may be a tool for the early diagnosis of LL patients.
- Published
- 2012
- Full Text
- View/download PDF